In high-risk B-ALL, IKAROS’s ability to regulate MTOR expression is abolished due to deletion of one IKZF1 allele and phosphorylation of the IKAROS protein by oncogenic Casein Kinase II (CK2). The gene discussed is MTOR; the disease is precursor B-cell acute lymphoblastic leukemia.